AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
COST-EFFECTIVENESS OF INTERFERON RIBAVIRIN TREATMENT AMONG NONRESPONDERS TO INITIAL INTERFERON THERAPY FOR CHRONIC HEPATITIS-C/
Authors: KIM WR POTERUCHA JJ DICKSON ER GROSS JB
Citation: Wr. Kim et al., COST-EFFECTIVENESS OF INTERFERON RIBAVIRIN TREATMENT AMONG NONRESPONDERS TO INITIAL INTERFERON THERAPY FOR CHRONIC HEPATITIS-C/, Hepatology, 28(4), 1998, pp. 276-276
MODERATE TO SEVERE PORTOPULMONARY HYPERTENSION - IMPORTANT CORRELATESWITH DOPPLER-ECHOCARDIOGRAPHY IN LIVER-TRANSPLANT CANDIDATES
Authors: KIM WR KROWKA MJ PLEVAK DJ LEE JH RETTKE SR FRANTZ RF WIESNER RH
Citation: Wr. Kim et al., MODERATE TO SEVERE PORTOPULMONARY HYPERTENSION - IMPORTANT CORRELATESWITH DOPPLER-ECHOCARDIOGRAPHY IN LIVER-TRANSPLANT CANDIDATES, Hepatology, 28(4), 1998, pp. 759-759
LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN THE 90S -PATIENT SURVIVAL AND RESOURCE UTILIZATION
Authors: KIM WR WIESNER KH THERNEAU TM MALINCHOC M KROM RAF EVANS RW DICKSON ER CRIPPIN JS KLINTMALM GBG RAKELA J STARZL TE
Citation: Wr. Kim et al., LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN THE 90S -PATIENT SURVIVAL AND RESOURCE UTILIZATION, Hepatology, 28(4), 1998, pp. 907-907
OPTIMAL TIMING OF LIVER-TRANSPLANTATION FOR PRIMARY BILIARY-CIRRHOSIS
Authors: KIM WR WIESNER RH THERNEAU TM POTERUCHA JJ PORAYKO MK EVANS RW KLINTMALM GB CRIPPIN JS KROM RA DICKSON ER
Citation: Wr. Kim et al., OPTIMAL TIMING OF LIVER-TRANSPLANTATION FOR PRIMARY BILIARY-CIRRHOSIS, Hepatology, 28(1), 1998, pp. 33-38
DOES OPEN ACCESS TO COLONOSCOPY AFFECT ITS DIAGNOSTIC YIELD
Authors: KIM WR LOCKE GR EVANS RW ZINSMEISTER AR GOSTOUT CJ
Citation: Wr. Kim et al., DOES OPEN ACCESS TO COLONOSCOPY AFFECT ITS DIAGNOSTIC YIELD, Gastroenterology, 114(4), 1998, pp. 90-90
ECONOMIC-ANALYSIS OF INTERFERON RIBAVIRAN TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C WHO RELAPSE FOLLOWING INITIAL INTERFERON THERAPY/
Authors: KIM WR POTERUCHA JJ DICKSON ER GROSS JB
Citation: Wr. Kim et al., ECONOMIC-ANALYSIS OF INTERFERON RIBAVIRAN TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C WHO RELAPSE FOLLOWING INITIAL INTERFERON THERAPY/, Gastroenterology, 114(4), 1998, pp. 314-314
THE MAYO RISK SCORE INCREASES RAPIDLY IN THE TERMINAL PHASE OF PRIMARY SCLEROSING CHOLANGITIS
Authors: KIM WR LINDOR KD POTERUCHA JJ BENSON JT THERNEAU TM DICKSON ER
Citation: Wr. Kim et al., THE MAYO RISK SCORE INCREASES RAPIDLY IN THE TERMINAL PHASE OF PRIMARY SCLEROSING CHOLANGITIS, Gastroenterology, 114(4), 1998, pp. 315-315
QUALITY OF HEALTH-STATUS QUESTIONNAIRE (SF-36) IN THE ASSESSMENT OF HEALTH-STATUS IN PATIENTS WITH CHOLESTATIC LIVER-DISEASE
Authors: MALINCHOC H KIM WR LINDOR KD JORGENSEN RA PETZ JL
Citation: H. Malinchoc et al., QUALITY OF HEALTH-STATUS QUESTIONNAIRE (SF-36) IN THE ASSESSMENT OF HEALTH-STATUS IN PATIENTS WITH CHOLESTATIC LIVER-DISEASE, Gastroenterology, 114(4), 1998, pp. 396-396
ECONOMIC-IMPACT OF CYTOMEGALOVIRUS-INFECTION AND COST-EFFECTIVE OF PROPHYLACTIC STRATEGIES IN LIVER-TRANSPLANT RECIPIENTS
Authors: KIM WR BADLEY AD WIESNER RH SEABERG EC BENSON JT EVANS RW DICKSON ER KROM RAF PAYA CV
Citation: Wr. Kim et al., ECONOMIC-IMPACT OF CYTOMEGALOVIRUS-INFECTION AND COST-EFFECTIVE OF PROPHYLACTIC STRATEGIES IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 26(4), 1997, pp. 115-115
A REVISED NATURAL-HISTORY MODEL FOR PRIMARY SCLEROSING CHOLANGITIS OBVIATES THE NEED FOR LIVER HISTOLOGY
Authors: KIM WR THERNEAU TM WIESNER RH MALINCHOC M KAPLAN MM WILLIAMS R LINDOR KD DICKSON ER
Citation: Wr. Kim et al., A REVISED NATURAL-HISTORY MODEL FOR PRIMARY SCLEROSING CHOLANGITIS OBVIATES THE NEED FOR LIVER HISTOLOGY, Hepatology, 26(4), 1997, pp. 935-935
DOES ANTIMITOCHONDRIAL ANTIBODY STATUS AFFECT RESPONSE TO TREATMENT IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS - OUTCOMES OF URSODEOXYCHOLIC ACID THERAPY AND LIVER-TRANSPLANTATION
Authors: KIM WR POTERUCHA JJ JORGENSEN RA BATTS KP HOMBURGER HA DICKSON ER KROM RAF WIESNER RH LINDOR KD
Citation: Wr. Kim et al., DOES ANTIMITOCHONDRIAL ANTIBODY STATUS AFFECT RESPONSE TO TREATMENT IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS - OUTCOMES OF URSODEOXYCHOLIC ACID THERAPY AND LIVER-TRANSPLANTATION, Hepatology, 26(1), 1997, pp. 22-26
UTILIZATION OF COLONOSCOPY IN THE COMMUNITY - A PRELIMINARY-REPORT
Authors: KIM WR LOCKE GR GEIER GR ZINSMEISTER AR MELTON LJ EVANS RW GOSTOUT CJ
Citation: Wr. Kim et al., UTILIZATION OF COLONOSCOPY IN THE COMMUNITY - A PRELIMINARY-REPORT, Gastrointestinal endoscopy, 45(4), 1997, pp. 102-102
SHOULD HELICOBACTER-PYLORI BE ERADICATED PRIOR TO INITIATION OF A PROTON PUMP INHIBITOR FOR GASTROESOPHAGEAL REFLUX DISEASE
Authors: KIM WR LOCKE GR
Citation: Wr. Kim et Gr. Locke, SHOULD HELICOBACTER-PYLORI BE ERADICATED PRIOR TO INITIATION OF A PROTON PUMP INHIBITOR FOR GASTROESOPHAGEAL REFLUX DISEASE, Gastroenterology, 112(4), 1997, pp. 22-22
HEPATITIS-G INFECTION IN PATIENTS UNDERGOING INTERFERON TREATMENT FORCHRONIC HEPATITIS-C
Authors: BRANDHAGEN DJ POTERUCHA JJ GROSS JB KIM WR PEREZ RG GERMER JJ GOSSARD AA DETMER J KOLBERG J COLLINS M PERSING DH
Citation: Dj. Brandhagen et al., HEPATITIS-G INFECTION IN PATIENTS UNDERGOING INTERFERON TREATMENT FORCHRONIC HEPATITIS-C, Gastroenterology, 112(4), 1997, pp. 1230-1230
COST-EFFECTIVENESS OF 6 AND 12 MONTHS OF INTERFERON-ALPHA THERAPY FORCHRONIC HEPATITIS-C
Authors: KIM WR POTERUCHA JJ HERMANS JE THERNEAU TM DICKSON ER EVANS RW GROSS JB
Citation: Wr. Kim et al., COST-EFFECTIVENESS OF 6 AND 12 MONTHS OF INTERFERON-ALPHA THERAPY FORCHRONIC HEPATITIS-C, Annals of internal medicine, 127(10), 1997, pp. 866
HEPATITIS-G INFECTION AS DETERMINED BY BDNA IN PATIENTS WITH HEPATITIS-C UNDERGOING LIVER-TRANSPLANTATION - CLINICAL CHARACTERISTICS AND VIRAL LEVELS
Authors: BRANDHAGEN DJ GROSS JB POTERUCHA JJ KIM WR CHARLTON MR PEREZ RG GERMER JJ DETMER J KOLBERG J COLLINS M WIESNER RH PERSING DH
Citation: Dj. Brandhagen et al., HEPATITIS-G INFECTION AS DETERMINED BY BDNA IN PATIENTS WITH HEPATITIS-C UNDERGOING LIVER-TRANSPLANTATION - CLINICAL CHARACTERISTICS AND VIRAL LEVELS, Hepatology, 24(4), 1996, pp. 409-409
SERUM CREATININE OR GLOMERULAR-FILTRATION RATE - WHICH IS BETTER IN PREDICTING OUTCOME OF LIVER-TRANSPLANTATION
Authors: KIM WR THERNEAU TM CRIPPIN J KLINTMALM GBG KROM RAF WIESNER RH DICKSON ER
Citation: Wr. Kim et al., SERUM CREATININE OR GLOMERULAR-FILTRATION RATE - WHICH IS BETTER IN PREDICTING OUTCOME OF LIVER-TRANSPLANTATION, Hepatology, 24(4), 1996, pp. 458-458
CAN RESOURCE UTILIZATION AND QUALITY-OF-LIFE POSTTRANSPLANT BE PREDICTED BASED ON PREOPERATIVE VARIABLES
Authors: KIM WR THERNEAU TM EVANS RW STEERS JL WIESNER RH DICKSON ER
Citation: Wr. Kim et al., CAN RESOURCE UTILIZATION AND QUALITY-OF-LIFE POSTTRANSPLANT BE PREDICTED BASED ON PREOPERATIVE VARIABLES, Hepatology, 24(4), 1996, pp. 698-698
HEPATITIS-G INFECTION IN PATIENTS UNDERGOING INTERFERON TREATMENT FORCHRONIC HEPATITIS-C - CLINICAL CHARACTERISTICS AND HGV RNA LEVELS
Authors: BRANDHAGEN DJ POTERUCHA JJ GROSS JB KIM WR PEREZ RG GERMER JJ GOSSARD AA DETMER J KOLBERT J COLLINS M PERSING DH
Citation: Dj. Brandhagen et al., HEPATITIS-G INFECTION IN PATIENTS UNDERGOING INTERFERON TREATMENT FORCHRONIC HEPATITIS-C - CLINICAL CHARACTERISTICS AND HGV RNA LEVELS, Hepatology, 24(4), 1996, pp. 1445-1445
RECURRENCE OF NONALCOHOLIC STEATOHEPATITIS FOLLOWING LIVER-TRANSPLANTATION
Authors: KIM WR POTERUCHA JJ PORAYKO MK DICKSON ER STEERS JL WIESNER RH
Citation: Wr. Kim et al., RECURRENCE OF NONALCOHOLIC STEATOHEPATITIS FOLLOWING LIVER-TRANSPLANTATION, Transplantation, 62(12), 1996, pp. 1802-1805
QUANTIFYING THE ROLE OF HELICOBACTER-PYLORI IN GASTRIC CARCINOGENESIS- AN ACCELERATED FAILURE TIME MODEL
Authors: KIM WR THERNEAU TM LOCKE GR DICKSON ER
Citation: Wr. Kim et al., QUANTIFYING THE ROLE OF HELICOBACTER-PYLORI IN GASTRIC CARCINOGENESIS- AN ACCELERATED FAILURE TIME MODEL, Gastroenterology, 110(4), 1996, pp. 156-156
COST-EFFECTIVENESS OF 12-MONTHS OF INTERFERON-ALPHA TREATMENT FOR CHRONIC HEPATITIS-C
Authors: KIM WR POTERUCHA JJ GROSS JB DICKSON ER EVANS RW
Citation: Wr. Kim et al., COST-EFFECTIVENESS OF 12-MONTHS OF INTERFERON-ALPHA TREATMENT FOR CHRONIC HEPATITIS-C, Gastroenterology, 110(4), 1996, pp. 1233-1233
REVISITING HEPATIC RETRANSPLANTATION IN AN ERA OF MANAGED CARE AND INCREASING SHORTAGE OF DONOR LIVER
Authors: KIM WR MALINCHOC M EVANS RW DICKSON ER
Citation: Wr. Kim et al., REVISITING HEPATIC RETRANSPLANTATION IN AN ERA OF MANAGED CARE AND INCREASING SHORTAGE OF DONOR LIVER, Gastroenterology, 110(4), 1996, pp. 1233-1233
AUTOIMMUNE CHOLANGITIS - ANOTHER INDICATION FOR URSODEOXYCHOLIC ACID THERAPY
Authors: KIM WR JORGENSEN RA DICKSON ER LINDOR KD
Citation: Wr. Kim et al., AUTOIMMUNE CHOLANGITIS - ANOTHER INDICATION FOR URSODEOXYCHOLIC ACID THERAPY, Gastroenterology, 110(4), 1996, pp. 1233-1233
IS IT COST-EFFECTIVE TO SCREEN FOR HEPATOCELLULAR-CARCINOMA - A DECISION-ANALYTIC MODEL
Authors: PASHA TM KIM WR GORES G THERNEAU T DICKSON ER
Citation: Tm. Pasha et al., IS IT COST-EFFECTIVE TO SCREEN FOR HEPATOCELLULAR-CARCINOMA - A DECISION-ANALYTIC MODEL, Gastroenterology, 110(4), 1996, pp. 1291-1291
Risultati: 1-25 | 26-27